The results of the loss- and gain-of-function experiments in the present study clearly indicated that PPARα activation was beneficial in preventing HF development and that the cardioprotective effects of LCD-P were PPARα dependent (Fig. 6b–d). The gene discussed is PPARA; the disease is hydrops fetalis.